secwatch.observer — SEC 8-K summary
======================================

Issuer:     Doximity, Inc. (DOCS)
CIK:        0001516513
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001516513-25-000092
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Doximity Q1 revenue $145.9M (+15%), adj. EBITDA $79.8M (+21%), raises FY guidance
--------------------------------------------------------------------------------

- Revenue $145.9M (+15% YoY); net income $53.3M (36.5% margin); non-GAAP EPS $0.36.
- Adjusted EBITDA $79.8M (+21% YoY), margin 54.7%; operating cash flow $62.1M (+51%).
- FY2026 guidance raised: revenue $628M-$636M, adj. EBITDA $341M-$349M.
- AI suite fastest growing, up 5x YoY; over 630K prescribers used workflow tools.
- Acquired Pathway Medical (details in separate release).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516513/000151651325000092/0001516513-25-000092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516513/000151651325000092/docs-20250807.htm
  HTML page:      https://secwatch.observer/filing/0001516513-25-000092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer